Why generic and disease-specific quality-of-life instruments should be used together for the evaluation of patients with persistent allergic rhinitis

Clinical and Experimental Allergy

Volumn 35, Issue 3, 2005, Pages 288-298

  Leong, K P ^a   Yeak, S C L ^a   Saurajen, A S M ^a   Mok, P K H ^a   Earnest, A ^a   Siow, J K ^a   Chee, N W C ^a   Yeo, S B ^a   Khoo, M L ^a   Lee, J C Y ^a   Seshadri, R ^a   Chan, S P ^a   Tang, C Y ^a   Chng, H H ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Factor analysis; Medical Outcome Short Form 36; Persistent allergic rhinitis; Quality of life; Rasch modelling; Rhinoconjunctivitis Quality of Life Questionnaire; RQLQ; SF 36; Symptom score

Indexed keywords

ADULT; ALLERGIC RHINITIS; ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; SHORT FORM 36;

ADULT; CASE-CONTROL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, PERENNIAL; SENSITIVITY AND SPECIFICITY;

EID: 20244381834     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02201.x     Document Type: Article

References (48)

1. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118:622-9.
2. Thompson AK, Juniper E, Meltzer EO. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2000; 85:338-48.
3. Blaiss MS. Quality of life in allergic rhinitis. Ann Allergy Asthma Immunol 1999; 83:449-54.
4. Mackowiak JI. Fluticasone propionate aqueous nasal spray (FP) improves rhinitis quality of life and reduces lost labor costs (abstract). Ann Allergy 1994; 72:99.
5. Meltzer EO, Nathan RA, Selner JC, Storms W. Quality of life and rhinitic symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires. J Allergy Clin Immunol 1997; 99:S815-9.
6. Ellis AK, Day JH, Lundie MJ. Impact on quality of life during an allergen challenge research trial. Ann Allergy Asthma Immunol 1999; 83:33-9.
7. Bagenstose SE, Bernstein JA. Treatment of chronic rhinitis by an allergy specialist improves quality of life outcomes. Ann Allergy Asthma Immunol 1999; 83:524-8.
8. Juniper EF, Thompson AK, Roberts JN. Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. Allergy 2002; 57:201-6.
9. Lohr KN, Aaronson NK, Alonso J et al. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther 1996; 18:979-92.
10. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S147-334.
11. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21:77-83.
12. Juniper EF, Guyatt GH, Andersson B, Ferrie PJ. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy 1993; 70:225-30.
13. Kremer B, Klimek L, Bullinger M, Mosges R. Generic or disease-specific quality of life scales to characterize health status in allergic rhinitis? Allergy 2001; 56:957-63.
14. De Graaf-in't Veld T, Koenders S, Garrelds IM, van Wijk RG. The relationships between nasal hyperactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J Allergy Clin Immunol 1996; 98:508-13.
15. Van Cauwenberge P, Juniper EF. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy 2000; 30:891-9.
16. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000; 30:132-40.
17. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999; 104:364-9.
18. Juniper EF, Guyatt GH, Archer B, Ferrie PJ. Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of 'as needed' use. J Allergy Clin Immunol 1993; 92:66-72.
19. Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1999; 83:311-7.
20. Ciprandi G, Canonica WG, Grosclaude M, Ostinelli J, Brazzola GG, Bousquet J. Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis. Allergy 2002; 57:586-91.
21. Leong KP, Chan SP, Tang CY et al. Quality of life of patients with perennial allergic rhinitis: preliminary validation of the Rhinoconjunctivitis Quality of Life Questionnaire in Singapore. Asian Pac J Allergy Immunol 1999; 17:163-7.
22. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-83.
23. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1992; 31:247-63.
24. McHorney CA, Ware JE, Lu RJF, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32:40-66.
25. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994; 94:182-8.
26. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. Am J Respir Crit Care Med 2000; 162:1391-6.
27. Majani G, Baiardini I, Giardini A et al. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 2001; 56:313-7.
28. Fukuroku K, Ogino S. Quality of life in patients with perennial allergic rhinitis: using the Japanese version of the SF-36 Health Status Questionnaire. Arerugi 2001; 50:385-93.
29. Bousquet J, Duchateau J, Pignat JC et al. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol 1996; 98:309-16.
30. Burtin B, Duchateau J, Pignat JC, Donnelly F, Bousquet J. Further improvement of quality of life by cetirizine in perennial allergic rhinitis as a function of treatment duration. J Invest Allergol Clin Immunol 2000; 10:66-70.
31. Schapowal A. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. Br Med J 2002; 324:1-4.
32. Ellis AK, Rafeiro E, Day JH. Quality of life indices may be predictive of placebo and medication response to treatment for allergic rhinitis. Ann Allergy Asthma Immunol 2001; 86:393-6.
33. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey. Manual and interpretation guide, 2nd Edn. Boston, MA: The National Health Institute, New England Medical Centre, 1997.
34. Beaton DE, Bombardier C, Katz JN, Wright JG. A taxonomy for responsiveness. J Clin Epidemiol 2001; 54:1204-17.
35. Wright JG, Young NL. A comparison of different indices of responsiveness. J Clin Epidemiol 1997; 50:239-46.
36. Liang MH, Larson MG, Cullen KE, Schwarz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985; 28:542-7.
37. Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopaedic evaluation. Med Care 1990; 28:632-42.
38. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27:S178-89.
39. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987; 40:171-8.
40. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures - statistics and strategies for evaluation. Controlled Clin Trials 1991; 12:S142-A158.
41. Subhash S. Applied multivariate technique. USA: John Wiley & Sons, 1996.
42. Weinberger M, Oddone EZ, Samsa GP, Landsman PB. Are health-related quality-of-life measures affected by the mode of administration? J Clin Epidemiol 1996; 49:135-40.
43. Yeak S, John AB, Chee N, Chng HH. Rhinitis in Singapore. Allergy 1996; 51:757-8.
44. Liang MH Evaluating measurement responsiveness. J Rheumatol 1995; 22:1191-2.
45. Coste J, Guillemin F, Pouchot J, Fermanian J. Methodological approaches to shortening composite measurement scales. J Clin Epidemiol 1997; 50:247-52.
46. Guyatt GH, Berman LB, Townsend M, Taylor DW. Should study subjects see their previous responses? J Chronic Dis 1985; 38:1003-7.
47. Murawski MM, Miederhoff PA. On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis. Qual Life Res 1998; 7:11-22.
48. Bombardier C, Melfi CA, Paul J et al. Comparison of a generic and a disease-specific measure of pain and physical function after knee replacement surgery. Med Care 1995; 33:A131-44.